After a successful pilot that recruited 1,000 patients, NorthShore will now engage 10,000 people to receive Color's genomic testing in their primary care.
The company also said it will release its first polygenic risk score for cardiovascular disease early this year.
Fortune reports that a Philadelphia-area hospital system is offering its employees free genetic testing.
Two recent publications suggest that DeepVariant's machine learning is far superior to traditional methods of variant calling, especially with hardware accelerators.
Othman Laraki, the CEO and co-founder of Color Genomics chats with Barron's Penta.
The company presented Color Data as a resource for variant classification scientists and hopes it will inspire industry peers to similarly share data.
Stat News reports that pharmacogenomics testing in psychiatry may be ahead of the science.
Researchers led by MD Anderson’s Karen Lu want to know the most efficient genetic counseling strategy as more people are getting screened for cancer risk genes.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
Rainbow will offer Color's hereditary cancer and heart health genetic risk assessment tests to patients in Hong Kong.
A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.
A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.
Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.
In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.